Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
JACC. Cardiovascular Imaging
|
November 22, 2020
Early Mechanical Alterations in Phospholamban Mutation Carriers: Identifying Subclinical Disease Before Onset of Symptoms
Karim Taha, Wouter P Te Rijdt, Tom E Verstraelen, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
August 1, 2017
Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathy
Wouter P Te Rijdt, Z Joy van der Klooster, Edgar T Hoorntje, et al.
European Heart Journal. Cardiovascular Imaging
|
September 13, 2021
Optimal echocardiographic assessment of myocardial dysfunction for arrhythmic risk stratification in phospholamban mutation carriers
Karim Taha, Tom E Verstraelen, Remco de Brouwer, et al.
International Journal of Cardiology
|
May 8, 2025
High incidence of malignant arrhythmias and heart failure in patients with RBM20-associated cardiomyopathy: A multicenter cohort study and review of the literature
Martijn Tukker, Wouter P Te Rijdt, Ahmad S Amin, et al.
Circulation
|
April 30, 2021
Unfolded Protein Response as a Compensatory Mechanism and Potential Therapeutic Target in PLN R14del Cardiomyopathy
Dries A M Feyen, Isaac Perea-Gil, Renee G C Maas, et al.
Virchows Archiv : an International Journal of Pathology
|
March 10, 2023
Genetically determined cardiomyopathies at autopsy: the pivotal role of the pathologist in establishing the diagnosis and guiding family screening
Mary N Sheppard, Allard C van der Wal, Jytte Banner, et al.
European Journal of Heart Failure
|
October 24, 2017
The first titin (c.59926 + 1G > A) founder mutation associated with dilated cardiomyopathy
Edgar T Hoorntje, Karin Y van Spaendonck-Zwarts, Wouter P Te Rijdt, et al.
Scientific Reports
|
June 20, 2020
The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapy
Tim R Eijgenraam, Bastiaan J Boukens, Cornelis J Boogerd, et al.
Scientific Reports
|
October 3, 2020
Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy
Tim R Eijgenraam, Bastiaan J Boukens, Cornelis J Boogerd, et al.
European Heart Journal. Cardiovascular Imaging
|
April 11, 2018
Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging
Wouter P Te Rijdt, Judith N Ten Sande, Thomas M Gorter, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
JACC. Cardiovascular Imaging
|
November 22, 2020
Early Mechanical Alterations in Phospholamban Mutation Carriers: Identifying Subclinical Disease Before Onset of Symptoms
Karim Taha, Wouter P Te Rijdt, Tom E Verstraelen, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|
August 1, 2017
Phospholamban immunostaining is a highly sensitive and specific method for diagnosing phospholamban p.Arg14del cardiomyopathy
Wouter P Te Rijdt, Z Joy van der Klooster, Edgar T Hoorntje, et al.
European Heart Journal. Cardiovascular Imaging
|
September 13, 2021
Optimal echocardiographic assessment of myocardial dysfunction for arrhythmic risk stratification in phospholamban mutation carriers
Karim Taha, Tom E Verstraelen, Remco de Brouwer, et al.
International Journal of Cardiology
|
May 8, 2025
High incidence of malignant arrhythmias and heart failure in patients with RBM20-associated cardiomyopathy: A multicenter cohort study and review of the literature
Martijn Tukker, Wouter P Te Rijdt, Ahmad S Amin, et al.
Circulation
|
April 30, 2021
Unfolded Protein Response as a Compensatory Mechanism and Potential Therapeutic Target in PLN R14del Cardiomyopathy
Dries A M Feyen, Isaac Perea-Gil, Renee G C Maas, et al.
Virchows Archiv : an International Journal of Pathology
|
March 10, 2023
Genetically determined cardiomyopathies at autopsy: the pivotal role of the pathologist in establishing the diagnosis and guiding family screening
Mary N Sheppard, Allard C van der Wal, Jytte Banner, et al.
European Journal of Heart Failure
|
October 24, 2017
The first titin (c.59926 + 1G > A) founder mutation associated with dilated cardiomyopathy
Edgar T Hoorntje, Karin Y van Spaendonck-Zwarts, Wouter P Te Rijdt, et al.
Scientific Reports
|
June 20, 2020
The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapy
Tim R Eijgenraam, Bastiaan J Boukens, Cornelis J Boogerd, et al.
Scientific Reports
|
October 3, 2020
Author Correction: The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy
Tim R Eijgenraam, Bastiaan J Boukens, Cornelis J Boogerd, et al.
European Heart Journal. Cardiovascular Imaging
|
April 11, 2018
Myocardial fibrosis as an early feature in phospholamban p.Arg14del mutation carriers: phenotypic insights from cardiovascular magnetic resonance imaging
Wouter P Te Rijdt, Judith N Ten Sande, Thomas M Gorter, et al.
Page
of 3